why choose us

First received: August 01, 2023

Clinical Trial: A Study to Evaluate the Drug Levels, Physical and Chemical Changes, and Removal of BMS-986196 in Healthy Male Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Male Volunteers

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Single-center, Open-label Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of Orally Administered 60 mg BMS-986196, Including Radioactively Labeled [14C]-BMS-986196, in Hea

Brief Summary: The purpose of this study is to evaluate the excretion pathway of orally administered [14C]-BMS-986196 and to assess the safety and tolerability of orally administered BMS-986196.

Read more